Infertility Testing Market by Test Type (Ovulation Testing Kits, Hormonal Testing Kits, Semen Analysis Kits); Application (Female Infertility Testing, Male Infertility Testing); End-Use Industry (Fertility Clinics, Hospitals, Diagnostic Laboratories) and by Region; Insights & Forecast (2024 – 2030)

As per Intent Market Research, the Infertility Testing Market was valued at USD 1.2 Billion in 2024-e and will surpass USD 2.2 Billion by 2030; growing at a CAGR of 10.8% during 2025 - 2030.

The Infertility Testing Market has seen significant growth in recent years, driven by the increasing awareness of infertility issues and the rising demand for early detection of reproductive health problems. Infertility is a common concern affecting both men and women, and as more individuals seek solutions, the market for infertility testing has expanded. With a variety of test types available, such as ovulation testing kits, hormonal testing kits, and semen analysis kits, the market provides individuals and healthcare professionals with tools to assess fertility health. The rise of at-home testing kits, which offer privacy and convenience, alongside advanced diagnostic solutions in clinical settings, has further fueled the demand for infertility testing.

As the societal acceptance of fertility treatments grows and the awareness of infertility-related issues increases, the market is expected to continue its expansion. Additionally, more couples are choosing to test for infertility earlier, driving the demand for both male and female infertility testing services. Fertility clinics, diagnostic laboratories, and hospitals have become central players in the delivery of these services, providing accurate and timely testing for patients who seek answers to their fertility challenges.

Ovulation Testing Kits Are Largest Test Type Owing to Their Accessibility and Affordability

Ovulation testing kits are the largest segment in the infertility testing market due to their accessibility, affordability, and widespread use among women who are actively trying to conceive. These kits are designed to detect the surge in luteinizing hormone (LH) that precedes ovulation, helping women identify their most fertile days. This empowers individuals with the knowledge needed to time intercourse and increase their chances of pregnancy. The simplicity and ease of use of ovulation testing kits make them highly popular among women who prefer to monitor their fertility at home.

Ovulation kits are available over-the-counter in most pharmacies and are affordable, which has significantly contributed to their large market share. Additionally, the growing trend of self-care and home-based healthcare solutions has further driven the adoption of these kits. As they are often the first step in fertility testing, ovulation testing kits play a key role in the early detection of fertility issues, contributing to their dominance in the infertility testing market.

Semen Analysis Kits Are Fastest Growing Test Type Due to Increased Focus on Male Fertility

Semen analysis kits represent the fastest-growing test type in the infertility testing market, largely driven by the increasing recognition of male fertility issues. While infertility has historically been considered a female concern, a significant proportion of infertility cases are attributed to male factors. Semen analysis kits provide valuable insights into sperm count, motility, and morphology, enabling men to assess their reproductive health. The growing awareness of male infertility and its impact on overall fertility has led to an increased demand for semen analysis, both in clinical settings and for at-home testing.

Technological advancements in semen analysis kits, including the integration of smartphone apps and more accurate testing methods, have contributed to their growing popularity. Additionally, as couples increasingly seek comprehensive fertility evaluations, men are becoming more proactive in seeking fertility testing. This growing focus on male fertility, combined with the convenience and privacy offered by at-home semen analysis kits, is driving the rapid expansion of this segment in the market.

Fertility Clinics Are Largest End-Use Industry Due to Their Focused Fertility Services

Fertility clinics are the largest end-use industry in the infertility testing market, as they specialize in diagnosing and treating infertility. These clinics offer a wide range of services, from basic fertility testing to advanced assisted reproductive technologies (ART) such as in vitro fertilization (IVF). Fertility clinics often provide a comprehensive testing approach that includes both male and female infertility assessments, including semen analysis and hormonal testing. As these clinics cater specifically to individuals seeking fertility solutions, they play a central role in the delivery of infertility testing services.

The growth of fertility clinics is driven by the increasing demand for infertility treatments and the rising awareness of the availability of diagnostic services. Fertility clinics also benefit from the integration of advanced technologies that enable accurate and quick results, making them a primary destination for individuals seeking infertility testing. As more individuals seek professional help with fertility issues, fertility clinics remain the largest sector for infertility testing services.

North America Is Largest Region Owing to High Fertility Treatment Demand

North America is the largest region in the infertility testing market, largely due to the high demand for fertility treatments, increased awareness of infertility issues, and advanced healthcare infrastructure. The United States and Canada have some of the highest rates of fertility testing, driven by rising infertility rates and the growing acceptance of assisted reproductive technologies. The presence of world-class fertility clinics and diagnostic laboratories in North America has further fueled the adoption of infertility testing services.

The region's healthcare system also supports a high level of accessibility to infertility testing, with insurance coverage often extending to diagnostic services related to fertility treatments. Additionally, as the focus on family planning and reproductive health continues to grow, North America is expected to maintain its position as the largest market for infertility testing. The region’s continued investment in fertility research and advancements in diagnostic technology further strengthens its leadership in the global market.

Leading Companies and Competitive Landscape

The infertility testing market is competitive, with several key players offering a range of testing solutions for both male and female infertility. Major companies in the market include Thermo Fisher Scientific, Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers, which provide advanced diagnostic products such as ovulation testing kits, hormonal testing kits, and semen analysis kits. These companies leverage their established reputation in the healthcare industry and continue to innovate, focusing on improving the accuracy and user-friendliness of their products.

The competitive landscape is marked by product innovations, strategic partnerships, and increasing research and development efforts to cater to the growing demand for infertility testing services. Additionally, several startups and smaller companies are entering the market, offering unique testing solutions such as home-based kits and mobile-enabled devices. As the market grows, leading companies are likely to continue enhancing their product portfolios and expanding their presence in emerging markets, ensuring robust competition in the years to come.

Recent Developments:

• Thermo Fisher Scientific launched a new advanced hormonal testing kit for women aiming to detect fertility issues more accurately.
• CooperSurgical introduced a new semen analysis device, enhancing accuracy and providing quicker results for fertility clinics.
• Abbott Laboratories expanded its infertility testing portfolio with a home-based ovulation testing kit, improving convenience for users.
• Fertility Focus Ltd. received FDA approval for its latest fertility monitoring product, targeting female infertility diagnostics.
• Menarini Diagnostics unveiled a new laboratory-based fertility testing solution that provides faster and more comprehensive results for both male and female patients.

List of Leading Companies:

• Thermo Fisher Scientific Inc.
• CooperSurgical Inc.
• Abbott Laboratories
• Sigma-Aldrich (Merck KGaA)
• Fertility Focus Ltd.
• LIFE Worldwide
• BioTech Medical (Hologic)
• Ortho Clinical Diagnostics
• Genova Diagnostics
• LabCorp
• Beckman Coulter
• Menarini Diagnostics
• Vitrolife AB
• ELITechGroup
• Roche Diagnostics

Report Scope: